Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapytreated subjects with human immunodeficiency virus type 1 infection

Journal of NeuroVirology

Volumn 16, Issue 2, 2010, Pages 115-124

  Sun, Bing ^a   Abadjian, Linda ^a   Rempel, Hans ^a   Calosing, Cyrus ^a   Rothlind, Johannes ^a   Pulliam, Lynn ^a,b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene; HAART; HIV; Microarray neuropsychology; Monocyte

Indexed keywords

ANTIRETROVIRUS AGENT; APOLIPOPROTEIN E; BIOLOGICAL MARKER; CD14 ANTIGEN; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; ATTENTION DISTURBANCE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFORMATION PROCESSING; LEARNING; LYMPHOCYTE COUNT; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MICROARRAY ANALYSIS; MONOCYTE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS LOAD; WORKING MEMORY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; COGNITION DISORDERS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MONOCYTES; NEUROPSYCHOLOGICAL TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77952141251     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280903559789     Document Type: Article

References (55)

1. Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D (2008). Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3: e2516.
2. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
3. Benedict RH (1997). Brief Visuospatial Memory Test\Revised (BVMT-R). Odessa, FL: Psychological Assessment Resources.
4. Benton AL, Hamsher K, Sivan AB (1983). Multilingual aphasia examination, 3rd ed. Iowa City, IA: AJA Associates.
5. Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, Phillips A, Porter K (2008). Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63: 213-221.
6. Caradonna L, Mastronardi ML, Magrone T, Cozzolongo R, Cuppone R, Manghisi OG, Caccavo D, Pellegrino NM, Amoroso A, Jirillo E, Amati L (2002). Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr Pharm Des 8: 995-1005.
7. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26: 307-319.
8. Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 59: 1563-1567.
9. Clifford DB (2008). HIV-associated neurocognitive disease continuesintheantiretroviralera.TopHIVMed16:94-98.
10. Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S (2007). Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J NeuroVirol 13: 67-72.
11. Cysique LA, Maruff P, Brew BJ (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66: 1447-1450.
12. Delis DC, Kaplan E, Kramer JH, Ober BA (1987). California Verbal Learning Test\Second Edition (CVLT-II). San Antonio, TX: The Psychological Corporatino.
13. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, Mandrekar P, Szabo G (2007). Viral and host factors induce macrophage activation and loss of tolllike receptor tolerance in chronic HCV infection. Gastroenterology 133: 1627-1636.
14. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis R, Cherne M, Gelman B, Morgello S, Singer E, Grant I, Masliah E (2009). Clin-iconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J NeuroVirol 15: 1-11.
15. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E (1999). Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 9: 209-217.
16. Ferrier L, Berard F, Debrauwer L, Chabo C, Langella P, Bueno L, Fioramonti J (2006). Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol 168: 1148-1154.
17. First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured, Clinical Interview for DSM-IV (SCID-I; Clinician Version). Washington, DC: American Psychiatric Association.
18. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, Regulier EG, Richardson MW, Amini S, Morgello S, Khalili K, Rappaport J (2001). CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J NeuroVirol 7: 528-541.
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
20. Giulian D, Vaca K, Noonan CA (1990). Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250: 1593-1596.
21. Golden CJ (1978). Stroop Color and Work Test. Chicago, IL: Stoelting.
22. Gopukumar K, Rao SL, Satishchandra P, Dasgupta J, Ellis RJ, Subbakrishna D, Mariamma P, Kamat A, Desai A, Ravi V, Rao B, Satish K, Kumar M (2008). Cognitive changes in asymptomatic drug-naive human immunodeficiency virus type 1 clade C infection. J NeuroVirol 14: 1-6.
23. Grant I (2008). Neurocognitive disturbances in HIV. Int Rev Psychiatry 20: 33-47.
24. Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 107: 828-836.
25. Grant I, Sacktor H, McArthur J (2005). HIV neurocognitive disorders. In: The neurology of AIDS. Gendelman HE, Grant I, Everall IP, Lipton SA, Swindells S (eds). London: Oxford University Press, pp 357-373.
26. Heaton RK, Chelune, GJ, Talley JL, Kay GG, Curtiss G (1993). Wisconsin Cart Sorting Test (WCST) manual, revised and expanded edition. Odessa, FL: Psychological Assessment Resources.
27. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G (2004). Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neu-ropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources.
28. Heaton RK, GrantI, ButtersN, White DA, KirsonD, Atkinson JH, McCutchan JA, Taylor MJ, Kelly MD, Ellis RJ, etal (1995). The HNRC 500\neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1: 231-251.
29. Hill JM, Bhattacharjee PS, Neumann DM (2007). Apolipoprotein E alleles can contribute to the patho-genesis of numerous clinical conditions including HSV-1 corneal disease. Exp Eye Res 84: 801-811.
30. Hixson JE, Vernier DT (1990). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548.
31. Ihaka R, Gentleman R (1996). R: a language for data analysis and graphics. J Comput Graph Stat 5: 299-314.
32. Jernigan TL, Archibald S, Hesselink JR, Atkinson JH, Velin RA, McCutchan JA, Chandler J, Grant I (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol 50: 250-255.
33. Koopmans PP, Ellis R, Best BM, Letendre S (2009). Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration? Neth J Med 67: 206-211.
34. Lezak MD (2004). Neuropsychological assessment, 4th ed. Oxford, New York: Oxford University Press.
35. Liu Y, Tang XP, McArthur JC, Scott J, Gartner S (2000). Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neuro-Virol 6(Suppl 1): S70-S81.
36. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA (1992). Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32: 321-329.
37. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I (1997). Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neu-robehavioral Research Center. Ann Neurol 42: 963-972.
38. McArthur JC (2004). HIV dementia: an evolving disease. J Neuroimmunol 157: 3-10.
39. McArthur JC, Brew BJ, Nath A (2005). Neurological complications of HIV infection. Lancet Neurol 4: 543-555.
40. Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I (2006). Cortical and subcortical neurode-generation is associated with HIV neurocognitive impairment. AIDS 20: 879-887.
41. Navia B, Price R (2005). An overview of the clinical and biological features of the AIDS dementia complex. In: The neurology of AIDS. Gendelman HE, Grant I, Everall IP, Lipton SA, Swindells S (eds). Oxford, New York: Oxford University Press, pp 339-356.
42. Odiase FE, Ogunrin OA, Ogunniyi AA (2007). Memory performance in HIV/AIDS\a prospective case control study. Can J Neurol Sci 34: 154-159.
43. Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, Price R, Meyerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, Lenkinski RE, Cohen RA, Navia BA (2007). Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuro-psychiatry Clin Neurosci 19: 283-292.
44. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS (1997). Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695.
45. Pulliam L, Sun B, Rempel H (2004). Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 157: 93-98.
46. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007). The prevalence and incidence of neu-rocognitive impairment in the HAART era. AIDS 21: 1915-1921.
47. Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, Anderson J, Ratanasuwan W, Gendelman HE, Swindells S (2001). Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis 184: 699-706.
48. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E (2006). Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67: 311-314.
49. Sacktor N, Skolasky RL, Tarwater PM, McArthur JC, Selnes OA, Becker J, Cohen B, Visscher B, Miller EN (2003). Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology 61: 567-569.
50. Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL (1988). Neuropsychological outcome of zido-vudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319: 1573-1578.
51. Smith A (1982). Symbol Digit Modalities Test (SDMT) manual, revised edition. Los Angeles, CA: Western Psychological Services.
52. Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, McCutchan JA, Wallace MR, Atkinson JH, Grant I (1998). Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol 55: 161-168.
53. Struss DT, Stethem LL, Poirier CA (1987). Comparison of three tests of attention and rapid information processing across six age groups. Clin Neuropsychol 1: 139-152.
54. Valcour VG, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Ratto-Kim S, Apateerapong W, Shiramizu BT, Desouza MS, Chitpatima ST, Watt G, Chuenchitra T, Robertson KR, Paul RH, McArthur JC, Kim JH, Shikuma CM (2007). Neuropsychological abnormalities in patients with dementia in CRF 01-AE HIV-1 infection. Neurology 68: 525-527.
55. Wechsler D (1997). Wechsler Adult Intelligence Scale, 3rd ed. San Antonio, TX: The Psychological Corporation.